NasdaqCM - Nasdaq Real Time Price USD
Verastem, Inc. (VSTM)
6.69
+0.16
+(2.45%)
At close: May 7 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -0.77 | -0.76 | -2.8 | -1.5 |
| Low Estimate | -0.94 | -0.91 | -3.24 | -1.5 |
| High Estimate | -0.61 | -0.61 | -2.35 | -1.5 |
| Year Ago EPS | -0.98 | -0.61 | -3.01 | -2.8 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 9 | 8 |
| Avg. Estimate | 100k | 4.7M | 15.81M | 74.43M |
| Low Estimate | -- | -- | 5.43M | 27.8M |
| High Estimate | 800k | 35M | 56.29M | 121.9M |
| Year Ago Sales | -- | 10M | 10M | 15.81M |
| Sales Growth (year/est) | 0.00% | -53.00% | 58.09% | 370.82% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.87 | -1.06 | -0.82 | -0.74 |
| EPS Actual | -0.98 | -0.61 | -0.88 | -0.6 |
| Difference | -0.11 | 0.45 | -0.06 | 0.14 |
| Surprise % | -13.08% | 42.59% | -7.32% | 18.55% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.77 | -0.76 | -2.8 | -1.5 |
| 7 Days Ago | -0.77 | -0.76 | -2.8 | -1.45 |
| 30 Days Ago | -0.61 | -0.61 | -2.35 | -1.45 |
| 60 Days Ago | -0.81 | -0.75 | -2.8 | -1.45 |
| 90 Days Ago | -0.81 | -0.75 | -2.8 | -1.36 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | -- |
| Up Last 30 Days | 1 | -- | -- | -- |
| Down Last 7 Days | -- | 1 | -- | 1 |
| Down Last 30 Days | -- | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VSTM | 20.92% | -24.59% | 7.14% | 46.33% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Initiated | Jefferies: Buy | 4/10/2025 |
| Maintains | Mizuho: Outperform to Outperform | 4/9/2025 |
| Maintains | Guggenheim: Buy to Buy | 3/24/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/24/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 3/21/2025 |
| Maintains | B. Riley Securities: Buy to Buy | 1/31/2025 |
Related Tickers
NUVB Nuvation Bio Inc.
2.0400
-2.39%
REPL Replimune Group, Inc.
7.16
-4.53%
ABEO Abeona Therapeutics Inc.
5.27
-8.51%
RLAY Relay Therapeutics, Inc.
2.9500
-6.35%
RVMD Revolution Medicines, Inc.
37.66
+0.59%
URGN UroGen Pharma Ltd.
10.12
+4.44%
CRDF Cardiff Oncology, Inc.
2.4900
-2.35%
KPTI Karyopharm Therapeutics Inc.
6.11
-2.55%
LRMR Larimar Therapeutics, Inc.
2.1700
+3.33%
SNDX Syndax Pharmaceuticals, Inc.
9.99
-6.11%